A Novel Liposome-Based Adjuvant CAF01 for Induction of CD8 + Cytotoxic T-Lymphocytes (CTL) to HIV-1 Minimal CTL Peptides in HLA-A*0201 Transgenic Mice
Gregers Jacob Gram, Ingrid Karlsson, Else Marie Agger et al. · 2009
Read A Novel Liposome-Based Adjuvant CAF01 for Induction of CD8 + Cytotoxic T-Lymphocytes (CTL) to HIV-1 Minimal CTL Peptides in HLA-A*0201 Transgenic Mice by Gregers Jacob Gram, Ingrid Karlsson, Else Marie Agger et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006950.txt.
Description
Gregers Gram, Ingrid Karlsson, Else Marie Agger, and colleagues tested a vaccine adjuvant in PLOS ONE in 2009. Strong killer T cell responses are a prized feature of viral vaccines. Adjuvants are the helper ingredients that can coax such responses out. The team studied a new liposome-based adjuvant called CAF01.
They paired CAF01 with very small HIV-1 peptide antigens. Tests ran in transgenic mice carrying a human immune gene, HLA-A*0201. The goal was to raise CD8 cytotoxic T lymphocytes against those peptides. A working adjuvant of this kind could strengthen future HIV vaccine designs that rely on killer T cells.
Catalog record
| CREATOR | Gregers Jacob Gram, Ingrid Karlsson, Else Marie Agger et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006950